Viability of Pulsioflex Monitoring in ICU
- Conditions
- Cardiogenic Shock
- Interventions
- Device: Measurement of the Cardiac Output/ Cardiac Index
- Registration Number
- NCT04911985
- Lead Sponsor
- University of Zurich
- Brief Summary
Goal of the Study is to Study the precision of semi-invasive cardiac index monitoring by means of the ProAQT (PULSION Medical Systems SE) sensor, whereby the pulmonary artery catheter will serve as gold standard.
- Detailed Description
Goal of the Study is to Study the precision of semi-invasive cardiac index monitoring by means of the ProAQT (PULSION Medical Systems SE) sensor, whereby the pulmonary artery catheter will serve as gold standard.
Measurements will be performed contemporaly with both devices every 4 hours and all clinical and hemodynmaic parameters will be recorded, including but not limited to central venous pressure, wege pressure, mechanical ventilation pressures, blood pressures, volume balance as well as vasoaktive medikation doses. This precise evaluation shall serve to evaluate the precision of the ProAQT to estimate the cardiac index under different clinical situation in the intensive care unit. A precision difference of below 30% between both methods will be regarded as clinically irrelevant, suggesting equipoise between both methods.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 42
- In situ pulmonary artery catheter
- Above 16 years of age
- At least 36 hours of continuous hemodynamic monitoring with the pulmonary artery catheter planed
- Patients with:
- Permanent or pesisting Atrial Fibrilation or Ventricular Arrythmias
- Moderate to Severe Aortic Insuficiency or Aortic Stenosis
- Intravascular Cardiac Assist Device
- Planed removal of the pulmonary artery catheter <36 hours
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description ICU Patients with PAC Measurement of the Cardiac Output/ Cardiac Index All patients admitted to the Medical ICU of the University Hospital Zürich, complying with the inclusion criteria and monitored by a pilmonary artery catheter
- Primary Outcome Measures
Name Time Method Bias of proAQT measurement 51 Hours Bias between the Pulsion CI measurement and the gold standard CI measurement by Pulmonary artery catheterisation
- Secondary Outcome Measures
Name Time Method Percentage Error of CI Measurement 51 Hours Percentage Error of CI Measurement between Pulsion and PAC measurement
Trial Locations
- Locations (1)
University Hospital Zurich, Medical intensive care unit
🇨🇭Zurich, ZH, Switzerland